#High Pressure Contrast Media Injectors Market Opportunities
Explore tagged Tumblr posts
Text
Transforming Diagnostics with Advanced Nuclear Imaging Equipment
The global nuclear imaging equipment market size is expected to reach USD 7.91 billion by 2030, registering a CAGR of 3.23% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary factor contributing to the market is the increasing prevalence of chronic diseases and the growing demand for accurate and early diagnostic techniques. Nuclear imaging devices play a pivotal role in the diagnosis of conditions such as cancer, cardiovascular diseases, and neurological disorders, contributing to the expanding applications of these technologies in clinical settings.
Numerous technological advancements and ongoing research and development activities also play a pivotal role in driving market growth. A notable example is the introduction of hybrid imaging systems that integrate nuclear imaging with other modalities such as computed tomography (CT) and magnetic resonance imaging (MRI). These integrated solutions provide comprehensive diagnostic information, giving more efficient and precise patient assessments. For instance, as reported in an article by Siemens Healthcare in April 2023, doctors in Brazil and Argentina discovered that upgrading their PET/CT scanners not only enabled them to effectively address new patient demands and alleviate scheduling pressures but also surpassed expectations by creating opportunities to explore new areas of care.
Moreover, the aging population is a significant factor contributing to the growing demand for nuclear imaging in healthcare. As the elderly population is more prone to various health issues, there is an increase in the requirement for accurate diagnostic tools capable of aiding in the early detection and monitoring of age-related diseases.For instance, according to the World Health Organization (WHO), it is projected that by the year 2030, one in six people worldwide will be aged 60 years or over. This demographic shift emphasizes the increasing prevalence of an aging population and underscores the importance of advanced diagnostic tools, such as nuclear imaging, in addressing the healthcare needs of this demographic group.
Nuclear Imaging Equipment Market Segments Highlights
On the basis of modality, the single photon emission computed tomography (SPECT) segment dominated the market with the largest revenue share of 57.88 % in 2024. A key contributing factor is the cost-effectiveness associated with SPECT equipment and procedures.
On the basis of application, the oncology segment dominated the market with the largest revenue share of 48.99% in 2024. This is due to the growing prevalence of cancer worldwide and advanced nuclear imaging technology, notably PET and SPECT have seen significant expansion owing to their unmatched capability to thoroughly examine the molecular traits specific to cancer.
The cardiology segment is expected to grow at the fastest rate from 2025 to 2030. The rising incidence of cardiovascular diseases (CVDs) coupled with the increased awareness regarding nuclear imaging's diagnostic capabilities is anticipated to fuel market growth.
Among end-use, the hospitals segment captured the largest revenue share of 51.96% in 2024. Hospitals are adopting nuclear imaging equipment at an increasing rate.
In 2024, the North America nuclear imaging equipment market held a dominant position, capturing a significant share of 42.82%. This trend is expected to continue throughout the forecast period.
Browse through Grand View Research's Medical Imaging Industry Research Reports.
The global high pressure contrast media injectors market size was valued at USD 254.1 million in 2023 and is anticipated to grow at a CAGR of 7.7% from 2024 to 2030.
The global forensic imaging market size was valued at USD 84.4 million in 2023 and is projected to grow at a CAGR of 10.5% from 2024 to 2030.
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global nuclear imaging equipment market report based on the modality, application, end-use, and region:
Nuclear Imaging Equipment Modality Outlook (Revenue, USD Million, 2018 - 2030)
SPECT
PET
Nuclear Imaging Equipment Application Outlook (Revenue, USD Million, 2018 - 2030)
Cardiology
Oncology
Neurology
Others
Nuclear Imaging Equipment End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Imaging Centers
R&D
Others
Nuclear Imaging Equipment Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
US
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Order a free sample PDF of the Nuclear Imaging Equipment Market Intelligence Study, published by Grand View Research.
0 notes
Text
High Pressure Contrast Media Injectors Market Size, Share, Economic Growth, Emerging Trends and Forecast till 2031
High Pressure Contrast Media Injectors Market 2023 by Technology, Manufacturers, Regions, Type, and Application, Forecast guide to light the excellent analysis on the market synopsis. The report offers a primary focus on important factors in the global High Pressure Contrast Media Injectors industry. The report includes perceptive information about gross revenue, cost, value, capacity, pricing, and profit margins concerning historical analysis and forecast estimation for the 2023 to 2031 time period. It presents a close overview of the market's restraints, challenges, opportunities, major drivers and current market trends, the supply chain and share market, and strategies impacting the global market along with estimates and forecasts of revenue and share analysis.
Major Key Players of the Market:
Guerbet Group
Bayer HealthCare LLC
Medtron AG
Bracco Group
Sino Medical-Device Technology Co.
Apollo RT Co. Ltd.
ulrich GmbH & Co. KG
NemotoKyorindo Co., Ltd.
GE Healthcare
Get Sample Report With Graphs and Table @ https://www.growthplusreports.com/inquiry/request-sample/high-pressure-contrast-media-injectors-market/8712
SEGMENTATION
GLOBAL HIGH PRESSURE CONTRAST MEDIA INJECTORS MARKET - ANALYSIS & FORECAST, BY PRODUCT
Consumables
Syringes
Tubing
Others
Injector Systems
GLOBAL HIGH PRESSURE CONTRAST MEDIA INJECTORS MARKET - ANALYSIS & FORECAST, BY TYPE
Syringeless Injectors
Single Head Injectors
Dual Head Injectors
GLOBAL HIGH PRESSURE CONTRAST MEDIA INJECTORS MARKET - ANALYSIS & FORECAST, BY APPLICATION
Endovascular Surgery
Interventional Cardiology
Interventional Radiology
Others
GLOBAL HIGH PRESSURE CONTRAST MEDIA INJECTORS MARKET - ANALYSIS & FORECAST, BY END USER
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers
The High Pressure Contrast Media Injectors market has witnessed a growth from Multimillion USD to Multimillion USD from 2018 to 2022. With a Impressive CAGR, this market is estimated to reach Multimillion USD in 2031.
The report focuses on the High Pressure Contrast Media Injectors market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
This study also covers company profiling, specifications and product picture, sales, market share and contact information of various regional, international and local vendors of High Pressure Contrast Media Injectors Market. The market proposition is frequently developing ahead with the rise in scientific innovation and MandA activities in the industry. Additionally, many local and regional vendors are offering specific application products for varied end-users. The new merchant applicants in the market are finding it hard to compete with the international vendors based on reliability, quality and modernism in technology.
For More Information or Query or Customization before buying, Visit at: https://www.growthplusreports.com/inquiry/customization/high-pressure-contrast-media-injectors-market/8712
Market segment by Region/Country including: -
-North America (United States, Canada and Mexico)
-Europe (Germany, UK, France, Italy, Russia and Spain etc.)
-Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
-South America (Brazil, Argentina and Colombia etc.)
-Middle East and Africa (South Africa, UAE and Saudi Arabia etc.)
High Pressure Contrast Media Injectors Market TOC: https://www.growthplusreports.com/report/toc/high-pressure-contrast-media-injectors-market/8712
FIVE FORCES and PESTLE ANALYSIS:
In order to better understand Market condition five forces analysis is conducted that includes Bargaining power of buyers, Bargaining power of suppliers, Threat of new entrants, Threat of substitutes, Threat of rivalry.
-Political (Political policy and stability as well as trade, fiscal and taxation policies)
-Economical (Interest rates, employment or unemployment rates, raw material costs and foreign exchange rates)
-Social (Changing family demographics, education levels, cultural trends, attitude changes and changes in lifestyles)
-Technological (Changes in digital or mobile technology, automation, research and development)
-Legal (Employment legislation, consumer law, health and safety, international as well as trade regulation and restrictions)
-Environmental (Climate, recycling procedures, carbon footprint, waste disposal and sustainability)
Purchase this report now at 20% flat discount @ https://www.growthplusreports.com/checkout-8712
Visit our report store at - https://www.growthplusreports.com/report-store
Manan Sethi
Director, Market Insights
Email: [email protected]
256 Chapman Road
STE 105-4, Newark,
New Castle - 19702, USA
Phone no: +1 888 550 5009
Web: https://www.growthplusreports.com/
About US:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020."
0 notes
Text
#High Pressure Contrast Media Injectors Market Size#High Pressure Contrast Media Injectors Market Share#High Pressure Contrast Media Injectors Market Trends#High Pressure Contrast Media Injectors Market Growth#High Pressure Contrast Media Injectors Market Demands#High Pressure Contrast Media Injectors Market Opportunities#High Pressure Contrast Media Injectors Market scope#High Pressure Contrast Media Injectors Market value#High Pressure Contrast Media Injectors Market Strategies#High Pressure Contrast Media Injectors Market Analysis.
0 notes
Text
Industry analysis provides a company with an understanding of its position relative to other companies in the industry. This can help them identify opportunities and potential threats, so they can prepare for the present and future. MRI Research helps organizations to figure out whats happening in a given industry, including demand and supply statistics, degree of competition, state of competition with other emerging industries, future prospects considering technological changes, and external factors on the industry.
0 notes
Text
Contrast Media Injectors Market worth $1.9 billion by 2025
The global contrast media injectors market size is estimated to be USD 1.3 billion in 2020 and projected to reach USD 1.9 billion by 2025, at a CAGR of 7.4% between 2020 and 2025. Factors such as the growing prevalence of cancer and CVD; a large number of approvals for contrast agents; and increasing investments, funds, and grants by government organizations are driving the growth of the contrast media injectors market. However, the high cost of contrast media injectors and consumables & accessories is restraining the growth of the market to a certain extent.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96046959
Opportunity: IT-enabled solutions for contrast media injectors
Contrast media injectors are now enabled with an LCD screen to maintain flow rates and monitor patient status. Also, market players are introducing new software for injector systems that can generate data in real-time. Information such as contrast media flow rate, injection pressure, injection speed, and type of contrast media can be easily accessed through this software. The IT department of a hospital can connect this software directly to their hospital information systems or electronic medical records and access patient data from picture archiving and communication systems. This reduces the time, error rate, and effort to upload statistical data and images manually.
North America accounted for the largest share of the Contrast Media Injector market in 2018, while the Asia Pacific market is expected to register the highest growth during the forecast period
Geographically, the contrast media injector market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. Asia Pacific is expected to grow at the highest CAGR during the forecast period, primarily due to factors such as the rising R&D investments and favorable demographic scenario in China, rising aging population and cancer incidence in Japan, growing investment in the Indian radiology market, and increasing focus of market players & increasing government support to strengthen healthcare service delivery in other countries are driving the growth of this regional segment.
Key Market Players
Major players in this market include Bayer Ag (Germany), Bracco Imaging S.P.A (Italy), Guerbet Group (France), Ulrich GmbH & Co. KG (Germany), Nemoto Kyorindo Co., Ltd (Japan), Sino Medical-Device Technology Co., Ltd. (Sinomdt) (China), APOLLO RT Co. Ltd. (Hongkong), Shenzhen Anke High-tech Co. Ltd (China), Shenzen Seacrown Electromechanical Co Ltd. (China), and Medtron AG (Germany).
0 notes